Dec 9, 2021 | Case Studies
Great success so far achieved in the PharmAust monepantel trials for canine lymphoma Great success has been achieved by PharmAust in its clinical trials testing the drug monepantel as an anticancer agent for pet dogs with treatment naïve B cell lymphoma. PharmAust has...
